Evidence map›Paper›PMID 37180926›Full record

ReviewHeliyon2023

Neuroprotective mechanisms of Asiatic acid.

Liuyun Ding, Tiantian Liu, Jin Ma

Abstract readReview
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Asiatic acid promotes CD8Acta pharmacologica Sinica · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Can Asiatic Acid fromCancers · 2024
    Review
  15. Review
  16. Surgical neurology international · 2024
    Review
  17. The effect ofSurgical neurology international · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Liuyun DingDepartment of Emergency Medicine, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, 215300, China.
Tiantian LiuShanghai Seventh's People's Hospital, An Affiliate of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China.
Jin MaDepartment of Emergency Medicine, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, 215300, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asiatic acid (AA) is the most crucial component of Asiaticoside in many edible and medicinal plants. It has diverse biological activities such as anti-inflammatory, antioxidant, anti-infective, and anti-tumor. Additionally, AA has been intensively studied in the last decades. It has shown great potential in the treatment of various neurological diseases such as spinal cord injury (SCI), cerebral ischemia, epilepsy, traumatic brain injury (TBI), neural tumors, Alzheimer's disease (AD), and Parkinson's disease (PD). Moreover, AA provides pertinent data for neuroprotective signaling pathways, and its substantial neuroprotective ability makes it a novel candidate for developing drugs that target the central nervous system.

Indexed as

Asiatic acidCentral nervous systemMolecular targetsNeuroprotectionSignaling pathways

Identifiers

PMID37180926
PMCPMC10172897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.